Pharmacodynamics of antiinfective therapy : Taking what we know to the patient's bedsideRODVOLD, Keith A.Pharmacotherapy. 2001, Vol 21, Num 11, pp 319S-330S, issn 0277-0008, 2Article

Antibiotic pharmacodynamics : Integration of science with therapeutic decisionsRODVOLD, Keith A.Pharmacotherapy. 2001, Vol 21, Num 11, issn 0277-0008, p. 291S, 2Article

Clinical Relevance of Pharmacodynamic StudiesRODVOLD, Keith A.Pharmacotherapy. 2001, Vol 21, Num 11, issn 0277-0008, 42 p., 2Serial Issue

Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid: Focus on Antifungal, Antitubercular and Miscellaneous Anti-Infective AgentsRODVOLD, Keith A; YOO, Liz; GEORGE, Jomy M et al.Clinical pharmacokinetics. 2011, Vol 50, Num 11, pp 689-704, issn 0312-5963, 16 p.Article

Pharmacokinetics and pharmacodynamics of fluoroquinolonesRODVOLD, Keith A; NEUHAUSER, Melinda.Pharmacotherapy. 2001, Vol 21, Num 10, pp 233S-252S, issn 0277-0008, 2Article

Vancomycin for Surgical Prophylaxis?CRAWFORD, Tonya; RODVOLD, Keith A; SOLOMKIN, Joseph S et al.Clinical infectious diseases. 2012, Vol 54, Num 10, pp 1474-1479, issn 1058-4838, 6 p.Article

Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid: Focus on Antibacterial AgentsRODVOLD, Keith A; GEORGE, Jomy M; YOO, Liz et al.Clinical pharmacokinetics. 2011, Vol 50, Num 10, pp 637-664, issn 0312-5963, 28 p.Article

What in vitro models of infection can and cannot doWHITE, Roger L.Pharmacotherapy. 2001, Vol 21, Num 11, pp 292S-301S, issn 0277-0008, 2Article

The Empirical Combination of Vancomycin and a β-Lactam for Staphylococcal BacteremiaMCCONEGHY, Kevin W; BLEASDALE, Susan C; RODVOLD, Keith A et al.Clinical infectious diseases. 2013, Vol 57, Num 12, pp 1760-1765, issn 1058-4838, 6 p.Article

Prolonged Infusions of β-Lactam Antibiotics: Implication for Antimicrobial Stewardship : ANTIMICROBIAL STEWARDSHIPGEORGE, Jomy M; TOWNE, Trent G; RODVOLD, Keith A et al.Pharmacotherapy. 2012, Vol 32, Num 8, pp 707-721, issn 0277-0008, 15 p.Article

Methicillin-Resistant Staphylococcus aureus Therapy: Past, Present, and FutureRODVOLD, Keith A; MCCONEGHY, Kevin W.Clinical infectious diseases. 2014, Vol 58, issn 1058-4838, S20-S27, SUP1Article

Tigecycline : A novel broad-spectrum antimicrobialSLOVER, Christine M; RODVOLD, Keith A; DANZIGER, Larry H et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 6, pp 965-972, issn 1060-0280, 8 p.Article

Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjectsGOTFRIED, Mark H; DANZIGER, Larry H; RODVOLD, Keith A et al.Journal of antimicrobial chemotherapy (Print). 2003, Vol 52, Num 3, pp 450-456, issn 0305-7453, 7 p.Article

Steady-state plasma and intrapulmonary concentrations of Levofloxacin and ciprofloxacin in healthy adult subjectsGOTFRIED, Mark H; DANZIGER, Larry H; RODVOLD, Keith A et al.Chest. 2001, Vol 119, Num 4, pp 1114-1122, issn 0012-3692Article

Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized PatientsLODISE, Thomas P; PATEL, Nimish; LOMAESTRO, Ben M et al.Clinical infectious diseases. 2009, Vol 49, Num 4, pp 507-514, issn 1058-4838, 8 p.Article

Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulationLODISE, Thomas P; LOMAESTRO, Ben; RODVOLD, Keith A et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 12, pp 4718-4724, issn 0066-4804, 7 p.Article

Comparison of Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Solithromycin (CEM-101) in Healthy Adult SubjectsRODVOLD, Keith A; GOTFRIED, Mark H; STILL, J. Gordon et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 10, pp 5076-5081, issn 0066-4804, 6 p.Article

Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjectsCHANDORKAR, Gurudatt; HUNTINGTON, Jennifer A; GOTFRIED, Mark H et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 10, pp 2463-2469, issn 0305-7453, 7 p.Article

Cerebrospinal fluid concentrations of quinupristin-dalfopristin in a patient with vancomycin-resistant Enterococcus faecalis ventriculitisGAREY, Kevin W; TESORO, Eljim; MUGGIA, Victoria et al.Pharmacotherapy. 2001, Vol 21, Num 6, pp 748-750, issn 0277-0008Article

Influence of Body Weight, Ethnicity, Oral Contraceptives, and Pregnancy on the Pharmacokinetics of Azithromycin in Women of Childbearing AgeFISCHER, James H; SARTO, Gloria E; HABIBI, Mitra et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 2, pp 715-724, issn 0066-4804, 10 p.Article

Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic modelHERMSEN, Elizabeth D; HOVDE, Laurie B; SPRANDEL, Kelly A et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 2, pp 685-689, issn 0066-4804, 5 p.Article

Effects of six-week clarithromycin therapy in corticosteroid-dependent asthma: A randomized, double-blind, placebo-controlled pilot studyGOTFRIED, Mark H; JUNG, Rose; MESSICK, Chad R et al.Current therapeutic research. 2004, Vol 65, Num 1, pp 1-12, issn 0011-393X, 12 p.Article

Influence of Gestational Age and Body Weight on the Pharmacokinetics of Labetalol in PregnancyFISCHER, James H; SARTO, Gloria E; RODVOLD, Keith A et al.Clinical pharmacokinetics. 2014, Vol 53, Num 4, pp 373-383, issn 0312-5963, 11 p.Article

Penetration of GSK1322322 into Epithelial Lining Fluid and Alveolar Macrophages as Determined by Bronchoalveolar LavageNADERER, Odin J; RODVOLD, Keith A; JONES, Lori S et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 1, pp 419-423, issn 0066-4804, 5 p.Article

Adverse events associated with the use of oral cephalosporins/cephemsMITROPOULOS, Isaac F; ROTSCHAFER, John C; RODVOLD, Keith A et al.Diagnostic microbiology and infectious disease. 2007, Vol 57, Num 3S, issn 0732-8893, 67S-76S, SUPArticle